Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dimethyl phthalate is a small molecule organic compound classified as a benzoic acid ester. It is primarily used as a plasticizer in the manufacture of plastics such as polyvinyl chloride (PVC), and also serves as an ingredient in insect repellents and various industrial applications including lacquers, adhesives, coatings for cellulose films and fibers, explosives manufacturing, printing inks and paper coatings. Dimethyl phthalate is absorbed via the gastrointestinal tract or skin but is rapidly cleared from the body with no significant accumulation. Toxicological data indicate low acute toxicity; chronic exposure may affect kidneys and other organs in animal studies. There is insufficient evidence to classify it regarding carcinogenicity or reproductive toxicity in humans. Its mechanism of action when used as an insect repellent does not involve direct binding to estrogen or androgen receptors[3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dimethyl phthalate.